Urinary metabolomics on the biochemical profiles in diet-induced hyperlipidemia rat using ultraperformance liquid chromatography coupled with quadrupole time-of-flight SYNAPT high-definition mass spectrometry

Journal of Analytical Methods in Chemistry

Volumn 2014, Issue , 2014, Pages

  Miao, Hua ^a   Chen, Hua ^a   Zhang, Xu ^a   Yin, Lu ^a   Chen, Dan Qian ^a   Cheng, Xian Long ^b   Bai, Xu ^c   Wei, Feng ^b  

^a NORTHWEST UNIVERSITY   (China)

^b NATIONAL INSTITUTES FOR FOOD AND DRUG CONTROL   (China)

^c Waters Technologies Shanghai Ltd   (China)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYLADENOSINE; 3 O METHYLDOPA; 5 METHYLCYTOSINE; AMINO ACID; BILE ACID; BIOCHEMICAL MARKER; CARBOXYLIC ACID; CITRIC ACID; CREATININE; FATTY ACID; NUCLEOSIDE; OLEAMIDE; PHENYLALANINE; PROLINE; TRYPTOPHAN; TYROSINE; URSODEOXYCHOLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE ACID METABOLISM; CONTROLLED STUDY; HYPERLIPIDEMIA; MALE; METABOLOMICS; NONHUMAN; PRIORITY JOURNAL; QUADRUPOLE MASS SPECTROMETRY; QUADRUPOLE TIME OF FLIGHT SYNAPT HIGH DEFINITION MASS SPECTROMETRY; RAT; REPRODUCIBILITY; TANDEM MASS SPECTROMETRY; TIME OF FLIGHT MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; URINALYSIS; URINE;

EID: 84897073371     PISSN: 20908865     EISSN: 20908873     Source Type: Journal    
DOI: 10.1155/2014/184162     Document Type: Article

References (29)

1. Nicholson J. K., Lindon J. C., Holmes E., 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999 29 11 1181 1189 2-s2.0-0032694577
2. Nicholson J. K., Connelly J., Lindon J. C., Holmes E., Metabonomics: a platform for studying drug toxicity and gene function. Nature Reviews Drug Discovery 2002 1 2 153 161 2-s2.0-0036463681 10.1038/nrd728 (Pubitemid 41646523)
3. Lindon J. C., Holmes E., Bollard M. E., Stanley E. G., Nicholson J. K., Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis. Biomarkers 2004 9 1 1 31 2-s2.0-2442719174 10.1080/13547500410001668379 (Pubitemid 38660013)
4. O'Keefe J. H., Bell D. S. H., Postprandial hyperglycemia/hyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor. The American Journal of Cardiology 2007 100 5 899 904 2-s2.0-34547957993 10.1016/j.amjcard. 2007.03.107 (Pubitemid 47268287)
5. Esteve E., Ricart W., Fernández-Real J. M., Dyslipidemia and inflammation: an evolutionary conserved mechanism. Clinical Nutrition 2005 24 1 16 31 2-s2.0-12744263365 10.1016/j.clnu.2004.08.004
6. Genest J., McPherson R., Frohlich J., Anderson T., Campbell N., Carpentier A., Couture P., Dufour R., Fodor G., Francis G. A., Grover S., Gupta M., Hegele R. A., Lau D. C., Leiter L., Lewis G. F., Lonn E., Mancini G. B. J., Ng D., Pearson G. J., Sniderman A., Stone J. A., Ur E., 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult-2009 recommendations. The Canadian Journal of Cardiology 2009 25 10 567 579 2-s2.0-70350360003
7. Adiels M., Olofsson S.-O., Taskinen M.-R., Borén J., Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 7 1225 1236 2-s2.0-46249093117 10.1161/ATVBAHA.107. 160192
8. Wu D. J., Zhu B. J., Wang X. D., Metabonomics-based omics study and atherosclerosis. Journal of Clinical Bioinformatics 2011 1 30
9. Liu F., Gan P. P., Wu H., Woo W. S., Ong E. S., Li S. F. Y., A combination of metabolomics and metallomics studies of urine and serum from hypercholesterolaemic rats after berberine injection. Analytical and Bioanalytical Chemistry 2012 403 3 847 856 2-s2.0-84858313154 10.1007/s00216-012-5923-9
10. Zhang X., Wu C., Wu H., Anti-hyperlipidemic effects and potential mechanisms of action of the caffeoylquinic acid-rich Pandanus tectorius fruit extract in hamsters fed a high fat-diet. PLoS ONE 2013 8 4 e61922 10.1371/journal.pone.0061922
11. Zhang Q., Wang G.-J., A J.-Y., Wu D., Zhu L.-L., Ma B., Du Y., Application of GC/MS-based metabonomic profiling in studying the lipid-regulating effects of Ginkgo biloba extract on diet-induced hyperlipidemia in rats. Acta Pharmacologica Sinica 2009 30 12 1674 1687 2-s2.0-74949095844 10.1038/aps.2009.173
12. Zhang Q., Wang G., A J., Ma B., Dua Y., Zhu L., Wu D., Metabonomic profiling of diet-induced hyperlipidaemia in a rat model. Biomarkers 2010 15 3 205 216 2-s2.0-77951677264 10.3109/13547500903419049
13. Morand J.-P. F., Macri J., Adeli K., Proteomic profiling of hepatic endoplasmic reticulum-associated proteins in an animal model of insulin resistance and metabolic dyslipidemia. The Journal of Biological Chemistry 2005 280 18 17626 17633 2-s2.0-24044453711 10.1074/jbc.M413343200 (Pubitemid 41388997)
14. Zhao Y. Y., Metabolomics in chronic kidney disease. Clinical Chimica Acta 2013 422 59 69 10.1016/j.cca.2013.03.033
15. Wrona M., Mauriala T., Bateman K. P., Mortishire-Smith R. J., O'Connor D., 'All-in-One' analysis for metabolite identification using liquid chromatography/hybrid quadrupole time-of-flight mass spectrometry with collision energy switching. Rapid Communications in Mass Spectrometry 2005 19 18 2597 2602 2-s2.0-25144468977 10.1002/rcm.2101 (Pubitemid 41338602)
16. Zhao Y.-Y., Liu J., Cheng X.-L., Bai X., Lin R.-C., Urinary metabonomics study on biochemical changes in an experimental model of chronic renal failure by adenine based on UPLC Q-TOF/MS. Clinica Chimica Acta 2012 413 5-6 642 649 2-s2.0-84856226309 10.1016/j.cca.2011.12.014
17. Zhao Y. Y., Shen X., Cheng X. L., Wei F., Bai X., Lin R. C., Urinary metabonomics study on the protective effects of ergosta-4, 6, 8(14), 22-tetraen-3-one on chronic renal failure in rats using UPLC Q-TOF/MS and a novel MS E data collection technique. Process Biochemistry 2012 47 12 1980 1987 10.1016/j.procbio.2012.07.008
18. Zhao Y. Y., Feng Y. L., Bai X., Tan X. J., Lin R. C., Mei Q., Ultra performance liquid chromatography-based metabonomic study of therapeutic effect of the surface layer of Poria cocos on adenine-induced chronic kidney disease provides new insight into anti-fibrosis mechanism. PLoS ONE 2013 8 3 e59617 10.1371/journal.pone.0059617
19. Zhao Y. Y., Lei P., Chen D. Q., Feng Y. L., Bai X., Renal metabolic profiling of early renal injury and renoprotective effects of Poria cocos epidermis using UPLC Q-TOF/HSMS/ MS E. Journal of Pharmaceutical and Biomedical Analysis 2013 81-82 202 209
20. Zhao Y. Y., Li H. T., Feng Y. L., Bai X., Lin R. C., Urinary metabonomic study of the surface layer of Poria cocos as an effective treatment for chronic renal injury in rats. Journal of Ethnopharmacology 2013 148 2 403 410 10.1016/j.jep.2013.04.018
21. Zhao Y. Y., Zhang L., Long F. Y., UPLC-Q-TOF/HSMS/ MS E -based metabonomics for adenine-induced changes in metabolic profiles of rat faeces and intervention effects of ergosta-4, 6, 8(14), 22-tetraen-3-one. Chemico-Biological Interactions 2013 201 1-3 31 38 10.1016/j.cbi.2012.12.002
22. Zhao Y.-Y., Cheng X.-L., Wei F., Bai X., Tan X. -J., Lin R. -C., Mei Q., Intrarenal metabolomic investigation of chronic kidney disease and its TGF- β 1 mechanism in induced-adenine rats using UPLC Q-TOF/HSMS/ MS E. Journal of Proteome Research 2013 12 2 692 703 10.1021/pr3007792
23. Zhao Y.-Y., Cheng X.-L., Wei F., Bai X., Lin R.-C., Application of faecal metabonomics on an experimental model of tubulointerstitial fibrosis by ultra performance liquid chromatography/high-sensitivity mass spectrometry with MS E data collection technique. Biomarkers 2012 17 8 721 729 10.3109/1354750X.2012. 724450
24. Lopansri B. K., Anstey N. M., Stoddard G. J., Mwaikambo E. D., Boutlis C. S., Tjitra E., Maniboey H., Hobbs M. R., Levesque M. C., Weinberg J. B., Granger D. L., Elevated plasma phenylalanine in severe malaria and implications for pathophysiology of neurological complications. Infection and Immunity 2006 74 6 3355 3359 2-s2.0-33646935700 10.1128/IAI.02106-05 (Pubitemid 43794524)
25. Fernstrom J. D., Fernstrom M. H., Tyrosine, phenylalanine, and catecholamine synthesis and function in the brain. The Journal of Nutrition 2007 137 6 1539S 1547S 2-s2.0-34249812090 (Pubitemid 46855503)
26. Zhang F., Jia Z., Gao P., Kong H., Li X., Chen J., Yang Q., Yin P., Wang J., Lu X., Li F., Wu Y., Xu G., Metabonomics study of atherosclerosis rats by ultra fast liquid chromatography coupled with ion trap-time of flight mass spectrometry. Talanta 2009 79 3 836 844 2-s2.0-67649359370 10.1016/j.talanta. 2009.05.010
27. Watford M., Glutamine metabolism and function in relation to proline synthesis and the safety of glutamine and proline supplementation. The Journal of Nutrition 2008 138 10 2003S 2007S 2-s2.0-54749147945
28. Lee S. H., Kim I., Chung B. C., Increased urinary level of oxidized nucleosides in patients with mild-to-moderate Alzheimer's disease. Clinical Biochemistry 2007 40 13-14 936 938 2-s2.0-34548162663 10.1016/j.clinbiochem. 2006.11.021 (Pubitemid 47307331)
29. Dyerberg J., Linolenate-derived polyunsaturated fatty acids and prevention of atherosclerosis. Nutrition reviews 1986 44 4 125 134 2-s2.0-0022703919